{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:20:20Z","timestamp":1767651620544,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00066-020-01743-4","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T14:02:51Z","timestamp":1611756171000},"page":"429-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a\u00a0single institution report of two cases"],"prefix":"10.1007","volume":"197","author":[{"given":"Elena","family":"Moreno-Olmedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Su\u00e1rez-Gironzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Filigheddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"M\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Sanjuan-Sanjuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Gorospe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Larrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5239-3852","authenticated-orcid":false,"given":"Escarlata","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"1743_CR1","doi-asserted-by":"publisher","unstructured":"Cuttler JM (2020). Letter to Dr. Stephen M Hahn. March 20, 2020. https:\/\/doi.org\/10.13140\/RG.2.2.19071.84646","DOI":"10.13140\/RG.2.2.19071.84646"},{"key":"1743_CR2","doi-asserted-by":"publisher","unstructured":"Dhawan G, Kapoor R, Dhawan R et al (2020) Low dose radiation therapy as a\u00a0potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother Oncol 147:212\u2013216. https:\/\/doi.org\/10.1016\/j.radonc.2020.05.002","DOI":"10.1016\/j.radonc.2020.05.002"},{"issue":"10229","key":"1743_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta\u00a0P, McAuley\u00a0DF, Brown\u00a0M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034","journal-title":"Lancet"},{"key":"1743_CR4","doi-asserted-by":"publisher","unstructured":"Kirkby C, Mackenzie M (2020) Is low dose radiation therapy a\u00a0potential treatment for COVID-19 pneumonia? Radiother Oncol 147:221. https:\/\/doi.org\/10.1016\/j.radonc.2020.04.004. Epub 2020 Apr 6. PMID: 32342871; PMCID: PMC7194710","DOI":"10.1016\/j.radonc.2020.04.004"},{"key":"1743_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01634-8","author":"D Chakrabarti","year":"2020","unstructured":"Chakrabarti\u00a0D, Verma\u00a0M (2020) Low-dose radiotherapy for SARS-CoV\u20112 pneumonia. Strahlenther Onkol. https:\/\/doi.org\/10.1007\/s00066-020-01634-8","journal-title":"Strahlenther Onkol"},{"key":"1743_CR6","first-page":"555","volume":"86","author":"EJ Calabrese","year":"2013","unstructured":"Calabrese\u00a0EJ, Dhawan\u00a0G (2013) How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med 86:555\u2013570","journal-title":"Yale J Biol Med"},{"key":"1743_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.rpor.2020.02.004","volume":"25","author":"L Torres Royo","year":"2020","unstructured":"Torres Royo\u00a0L, Antelo Redondo\u00a0G, Arquez Pianetta\u00a0M et al (2020) Low-dose radiation therapy for benign pathologies. Rep Pract Oncol Radiother 25:250\u2013254","journal-title":"Rep Pract Oncol Radiother"},{"key":"1743_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/09553000500385556","volume":"81","author":"D Schaue","year":"2005","unstructured":"Schaue\u00a0D, Jahns\u00a0J, Hildebrandt\u00a0G et\u00a0al (2005) Radiation treatment of acute inflammation in mice. Int J Radiat Biol 81:657\u2013667","journal-title":"Int J Radiat Biol"},{"key":"1743_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.radonc.2007.10.032","volume":"86","author":"M Arenas","year":"2008","unstructured":"Arenas\u00a0M, Gil\u00a0F, Gironella\u00a0M et al (2008) Time course of anti-inflammatory effect of low-dose radiotherapy: correlation with tgf-beta (1) expression. Radiother Oncol 86:399\u2013406","journal-title":"Radiother Oncol"},{"issue":"6","key":"1743_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/09553000701317358","volume":"83","author":"F R\u00f6del","year":"2007","unstructured":"R\u00f6del\u00a0F, Keilholz\u00a0L, Herrmann\u00a0M et al (2007) Radiobilogical mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol 83(6):357\u2013366","journal-title":"Int J Radiat Biol"},{"issue":"5","key":"1743_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson\u00a0ME et\u00a0al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J\u00a0Chron Dis 40(5):373\u2013383","journal-title":"J Chron Dis"},{"issue":"10223","key":"1743_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang\u00a0C, Wang\u00a0Y, Li\u00a0X et\u00a0al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"key":"1743_CR13","volume-title":"Report of the WHO-China joint mission on Coronavirus disease 2019 (COVID-19)","author":"WHO-China Joint Mission","year":"2020","unstructured":"WHO-China Joint Mission (2020) Report of the WHO-China joint mission on Coronavirus disease 2019 (COVID-19)"},{"key":"1743_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06817-6","author":"K Li","year":"2020","unstructured":"Li\u00a0K, Fang\u00a0Y, Li\u00a0W et al (2020) CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-020-06817-6","journal-title":"Eur Radiol"},{"key":"1743_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"M Oken","year":"1982","unstructured":"Oken\u00a0M, Creech\u00a0R, Tormey\u00a0D et\u00a0al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"1743_CR16","unstructured":"CTCAE v5.0 \u2013 November 27, 2017: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed 27\u00a0Nov 2017"},{"key":"1743_CR17","doi-asserted-by":"publisher","first-page":"104380","DOI":"10.1016\/j.jcv.2020.104380","volume":"127","author":"SK Alzghari","year":"2020","unstructured":"Alzghari\u00a0SK, Acu\u00f1a\u00a0VS (2020) Supportive treatment with tocilizumab for COVID-19: a systematic review. J\u00a0Clin Virol 127:104380. https:\/\/doi.org\/10.1016\/j.jcv.2020.104380","journal-title":"J Clin Virol"},{"key":"1743_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctro.2020.04.006","volume":"23","author":"PC Lara","year":"2020","unstructured":"Lara\u00a0PC et al (2020) Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a\u00a0cost-effective anti-inflammatory treatment. Clin Trans Radiat Oncol 23:27\u201329. https:\/\/doi.org\/10.1016\/j.ctro.2020.04.006","journal-title":"Clin Trans Radiat Oncol"},{"key":"1743_CR19","unstructured":"U.S. National Library of Medicine. https:\/\/clinicaltrials.gov\/. Accessed 20\u00a0Oct 2020"},{"key":"1743_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01635-7","author":"F R\u00f6del","year":"2020","unstructured":"R\u00f6del\u00a0F, Arenas\u00a0M, Ott\u00a0OJ (2020) Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Strahlenther Onkol. https:\/\/doi.org\/10.1007\/s00066-020-01635-7","journal-title":"Strahlenther Onkol"},{"key":"1743_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4031","author":"G Grasselli","year":"2020","unstructured":"Grasselli\u00a0G, Pesenti\u00a0A, Cecconi\u00a0M (2020) Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.4031","journal-title":"JAMA"},{"key":"1743_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30627-9","author":"A Remuzzi","year":"2020","unstructured":"Remuzzi\u00a0A, Remuzzi\u00a0G (2020) COVID-19 and Italy: what next? Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)30627-9","journal-title":"Lancet"},{"key":"1743_CR23","unstructured":"https:\/\/www.who.int\/es\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-march-2020. Accessed 3\u00a0Mar 2020"},{"key":"1743_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00066-006-1542-8","volume":"182","author":"KR Trott","year":"2006","unstructured":"Trott\u00a0KR, Kamprad\u00a0F (2006) Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol 182:431\u2013436","journal-title":"Strahlenther Onkol"},{"key":"1743_CR25","doi-asserted-by":"publisher","first-page":"20150405","DOI":"10.1259\/bjr.20150405","volume":"88","author":"SR Mckeown","year":"2015","unstructured":"Mckeown\u00a0SR, Hatfield\u00a0P, Prestwich\u00a0RJD et al (2015) Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermidate dose radiation. Br J Radiol 88:20150405","journal-title":"Br J Radiol"},{"key":"1743_CR26","doi-asserted-by":"publisher","unstructured":"Mazonakis M, Damilakis J (2017) Cancer risk after radiotherapy for benign diseases. Phys Med (42):285\u2013291. https:\/\/doi.org\/10.1016\/j.ejmp.2017.01.014. Epub 2017 Feb 8. PMID: 28189418","DOI":"10.1016\/j.ejmp.2017.01.014"},{"key":"1743_CR27","doi-asserted-by":"publisher","unstructured":"Hess CB et al Low-dose whole-lung radiation for COVID-19 pneumonia: planned day\u20117 interim analysis of a\u00a0registered clinical trial. December 126(23):5109\u20135113. https:\/\/doi.org\/10.1101\/2020.06.03.20116988","DOI":"10.1101\/2020.06.03.20116988"},{"key":"1743_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar\u00a0R, Perlman\u00a0S (2017) Pathogenichuman coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 39:529\u2013539. https:\/\/doi.org\/10.1007\/s00281-017-0629-x","journal-title":"Semin Immunopathol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-020-01743-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-020-01743-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-020-01743-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T15:09:06Z","timestamp":1622646546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-020-01743-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1743"],"URL":"https:\/\/doi.org\/10.1007\/s00066-020-01743-4","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2021,1,27]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"E.\u00a0Moreno-Olmedo, V.\u00a0Su\u00e1rez-Gironzini, M.\u00a0P\u00e9rez, T.\u00a0Filigheddu., C.\u00a0M\u00ednguez, A.\u00a0Sanjuan-Sanjuan, J.A.\u00a0Gonz\u00e1lez, D.\u00a0Rivas, L.\u00a0Gorospe, L.\u00a0Larrea and E.\u00a0L\u00f3pez declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Approved by the HM Hospitales Group Ethics Committee (CEIm) on April\u00a021, 2020. CEIm code 20.4.1597-GHM. Patients signed consent was obtained after verbal information on the procedure, objective and secondary effects of the treatment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}